Mr. Fred N. Boulos is Independent Director of Epicore Bionetworks Inc., since March 12, 2007. He is Principal, FNB Consulting Inc., a management consulting firm, 2003 to present; Contracts Manager, Alsthom Cegelec, Bouygues France & KBR J.V., a Chad/Cameroon Oil Exploration and Pipeline Project, 2001 to 2003. He has over 30 years of business experience.
The company has return on total asset (ROA) of 10.25 % which means that it generated profit of $10.25 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 10.52 % meaning that it generated $10.52 on every $100 dollars invested by stockholders.
The company has accumulated 498.1 K in total debt with debt to equity ratio (D/E) of 0.1 which may suggest the company is not taking enough advantage from borrowing. Epicore BioNetworks Inc has Current Ratio of 11.75 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Epicore BioNetworks Inc. designs, develops, and manufactures biotechnology solutions and specialty animal feeds worldwide. Epicore BioNetworks Inc [EBN] is traded on TSX Venture Exchange in Canada. It is located in Eastampton, NJ and employs 8 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory